Request Face2Gene
Team Edition

01Upload Photos

Take a new photo or
upload an existing one

02Search References 

Search and review genetic resources including LMD online, POSSUMweb, OMIM®, Orphanet and GeneReviews™

03Analyze Results

Analyze and reference to
validate your thoughts
and conclusions

Face2Gene Features

Face2Gene is Ideally Suited to Assist in Your Daily Clinical Practice, Incorporating the Following Unique Features:

Search Syndromes

Search and review genetic resources including LMD online, POSSUMweb, OMIM®, Orphanet and GeneReviews™

Complete HPO annotation

Complete HPO annotation, enhanced by our
facial dysmorphic feature detection

Powerful visualization tools

Side-by-side comparison with
published reference images or
with cases from your personal or team library

Customized reports

Customized reports with automatically
calculated WHO growth charts

Online Unknown Forum

Review and share thoughts on
undiagnosed and challenging cases in this
professionals-only forum

Case library

Keep your cases fully secure and backed-up in
your HIPAA compliant case library


Images Analyzed


Face2Gene users


Searchable Syndromes


Features Supported


InHelix integrates with Face2Gene to improve CNV analysis

LEUVEN, Belgium — July 14, 2016 — Diploid today announces an update of InHelix, its software for CNV analysis in rare disease diagnostics. InHelix now integrates with Face2Gene, a software platform that facilitates detection of facial dysmorphic features from facial photos. The integration between the two apps allows clinicians to directly access and use dysmorphic patterns detected by Face2Gene from within InHelix, making CNV analysis more accurate and efficient. In addition, InHelix users can auto-import general patient information.

“Face2Gene has been a game changer in rare disease diagnostics” says Dr. Aimé Lumaka, Diploid’s CMO. “It has finally introduced an objective, computer-aided dimension to the science of dysmorphology. Numerous clinicians report that it helps them to establish a correct diagnosis that might not be considered otherwise. As a tool for CNV analysis in rare disease diagnostics, one of InHelix’s strengths is to integrate as much phenotype data as possible. By interfacing with Face2Gene, we are making it even easier for our clients to leverage phenotype data, strengthening our lead in this area.”

Jul 14, 2016

FDNA to Launch Third Cycle of GIVE A FACE TO A SYNDROME at the ACMG Annual Meeting

Call for Research Proposals Issued at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting 2016

FDNA Inc. (Boston, MA) issued today a call to geneticists to submit research proposals to the third cycle of the GIVE A FACE TO A SYNDROME research program. The announcement coincides with the American College of Medical Genetics and Genomics (ACMG) Annual Meeting.

The third cycle of this research program will focus on the use of FDNA’s standardized and deep phenotyping technology, available through Face2Gene, to associate phenotypic features with genetic variants, demonstrating the potential of improved diagnostic yield of variant analysis.

“After the overwhelmingly positive outcome of the two previous cycles, resulting in numerous publications, talks and abstracts in some of the most prestigious venues in the world, we decided to further strengthen our partnership with the genetic research community,” said Nicole Fleischer, Head of Research Collaborations at FDNA.

Individuals and institutions interested in joining the third cycle of the GIVE A FACE TO A SYNDROME research program should submit a short proposal by 5:00 PM Eastern time on June 30, 2015. The call for research proposals is available to all geneticists worldwide and does not include financial support. Study results will be shared with the scientific community and may serve as the basis for scientific publication by the collaborators. Collaborators will receive full credit for their participation in the program. Applicants are invited to submit proposals in this link

Questions can be directed to info(at), or stop by booth #505 at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting in Tampa, Florida, March 9-11.

Mar 07, 2016

FDNA Announces New Grant for Genetic Testing of Patients with Unknown Diagnosis

Grant available exclusively for cases uploaded through the Face2Gene Online Unknown Forum

FDNA Inc. (Boston, MA) announced a new grant program for patients with an unknown diagnosis. Under this grant, FDNA will sponsor for genetic testing to be performed for patients with cases uploaded through the Face2Gene Online Unknown Forum.

The announcement was made at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting in Tampa, Florida and coincided with an announcement made at the Diagnostic Challenges session.

“FDNA is committed to making a positive impact, not only in the field of genetics, but also in the lives of patients,” said Dekel Gelbman, FDNA’s Chief Executive Officer. “These grants for genetic testing represent real hope for patients in our Face2Gene Online Unknown Forum, many of whom have exhausted their options for finding an answer to their symptoms.”

FDNA is inviting reference labs to join this initiative and extend this philanthropic effort so that more patients can get relief and conclude their diagnostic odyssey.

Genetic testing grants will be awarded to five patients, based on selection of a review committee made up of expert dysmorphologists.

Individuals and institutions interested in learning more about these grants, or who wish to partner with FDNA in this initiative can contact FDNA at info(at)FDNA(dot)com.

Mar 14, 2016

More news

Join the Face2Gene users community

What People Are Saying About Face2Gene

Dr. Michael R. Hayden

Dr. Michael R. Hayden

Chairman of FDNA’s Scientific Advisory Board & Steering Committee and Editor in Chief of Clinical Genetics

FDNA’s game-changing technology introduces an objective computer-aided dimension to the “art of dysmorphology”, transforming the analysis into an evidence-based science.

Dr. Zvi U. Borochowitz

Chairman (Retired) of The Simon Winter Institute for Human Genetics at Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine

Shortly after learning about Face2Gene, I’ve started to incorporate this amazing tool into my workflow. Soon enough, Face2Gene’s analysis flushed out references that I would not have considered for several of my patients, which turned out to be their correct diagnosis

Read More

Collaborate. Share. Promote.

Help us transform the art of dysmorphology into an evidence-based science. Facilitate innovative research, promote discovery of new genetic syndromes and improve recognition of known syndromes.

Join the FDNA Research Program

Save time and improve clinical outcomes through
collaboration & knowledge sharing

Register for Face2Gene Team Edition

Get the latest news from us

Enter your name and email address to receive our monthly newsletter.

required required